Literature DB >> 11181119

Fever interval before diagnosis, prior antibiotic treatment, and clinical outcome for young children with bacterial meningitis.

B K Bonsu1, M B Harper.   

Abstract

In young children, meningitis due to Streptococcus pneumoniae is preceded by a long interval from onset of fever to diagnosis of bacterial meningitis (hereafter known as "fever interval"), during which time the patient frequently contacts a clinician. By means of retrospective chart review, we compared the fever interval that preceded diagnosis with the complication rate among 288 young children (age, 3--36 months) who had bacterial meningitis (1984--1996), as stratified by causative organism and prior antibiotic treatment. Pathogens included S. pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis. Pneumococcus species were associated with the longest fever interval prior to diagnosis of meningitis, the highest frequency of contact with a clinician before hospitalization, and the highest rate of documented morbidity or mortality. For S. pneumoniae, there was an association between antibiotic treatment received at prior meetings with a clinician and a reduced rate of meningitis-related complications (odds ratio, 0.14; P=.02). Antibiotic treatment during such meetings is associated with a substantial reduction in disease-related sequelae.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181119     DOI: 10.1086/318700

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Timing of Administration of Antimicrobial Therapy in Bacterial Meningitis.

Authors:  William R. Short; Allan R. Tunkel
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663

2.  Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004).

Authors:  S Afifi; M O Wasfy; M A Azab; F G Youssef; G Pimentel; T W Graham; H Mansour; N Elsayed; K Earhart; R Hajjeh; F Mahoney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-05       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.